Your new post is loading...
Expensive biotech drugs now made in high-tech manufacturing plants can be grown much more cheaply in genetically engineered algae, according to a paper published Monday in the prestigious Proceedings of the National Academy of Sciences.
Manufacturing costs can be reduced by 90 percent for these drugs, translating into half off their sales price, said Stephen Mayfield, a UC San Diego professor and senior author of the paper.
